These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 239198)

  • 1. Fluorometric assay of bethanidine in plasma.
    Corder CN; Klaniecki TS; McDonald RH; Berlin C
    J Pharm Sci; 1975 May; 64(5):785-92. PubMed ID: 239198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bethanidine elimination from plasma.
    Corder CN
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):428-34. PubMed ID: 489762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bethanidine in plasma by liquid-chromatography with a microbore reversed-phase column.
    Shipe JR; Arlinghaus AF; Savory J; Wills MR; DiMarco JP
    Clin Chem; 1983 Oct; 29(10):1793-5. PubMed ID: 6616825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bethanidine dose, plasma levels, and antihypertensive effects.
    Corder CN
    J Clin Pharmacol; 1978; 18(5-6):249-58. PubMed ID: 641213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation.
    DiMarco JP; Sellers TD; Shipe JR; Savory J; Spyker DH
    Am Heart J; 1984 Nov; 108(5):1244-9. PubMed ID: 6496282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
    Bacaner MB; Benditt DG
    Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of bethanidine in hypertensive patients.
    Shen D; Gibaldi M; Israili A; Bellward G; Cunningham R; Throne M; Dayton P; McNay J
    Clin Pharmacol Ther; 1975 Mar; 17(3):363-73. PubMed ID: 1120401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent change in renal clearance of bethanidine in humans.
    Chremos AN; Shen D; Gibaldi M; Proctor JD; Newman JH
    J Pharm Sci; 1976 Jan; 65(1):140-2. PubMed ID: 1255421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension.
    Ramirez EA; Elson L; Gear AS; Oster JR; Talmers FN; Thomas JR
    Circulation; 1977 Mar; 55(3):519-25. PubMed ID: 319922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial bethanidine kinetics after single-dose intravenous infusion: correlation with plasma kinetics in closed-chest dogs.
    Anderson JL; Anastasiou-Nana M; Dayton VD; Creagar RN; Jensen RL; Wright GJ
    J Cardiovasc Pharmacol; 1985; 7(3):609-12. PubMed ID: 2410697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
    Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TO-DAY'S DRUGS. BETHANIDINE SULPHATE.
    BEWLEY TH
    Br Med J; 1964 Oct; 2(5413):865. PubMed ID: 14185642
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bethanidine sulfate: efficacy in prevention of ventricular tachyarrhythmias during programmed stimulation. Report of a multicenter study of 56 patients.
    Teichman SL; Waspe LE; Matos JA; Kim SG; Fisher JD
    J Am Coll Cardiol; 1985 Sep; 6(3):510-7. PubMed ID: 3897340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic action of bethanidine.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Wynn J; Keren G; Miura DS
    Am J Cardiol; 1984 Aug; 54(3):343-6. PubMed ID: 6465015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE USE OF BETHANIDINE IN THE TREATMENT OF HYPERTENSION.
    JOHNSTON AW; PRICHARD BN; ROSENTHEIM ML
    Lancet; 1964 Sep; 2(7361):659-61. PubMed ID: 14188906
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiological effects of bethanidine sulfate on guinea-pig papillary muscle.
    Inoue D; Nakanishi T; Asayama J; Katsume H; Ijichi H
    Eur J Pharmacol; 1985 Feb; 108(3):301-3. PubMed ID: 3987806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bethanidine dosing schedules for rapid control of blood pressure.
    Proctor JD; Evans EF; Wasserman AJ
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):257-65. PubMed ID: 822984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of bethanidine sulfate in the treatment of arterial hypertension].
    Cristodorescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(4):279-89. PubMed ID: 778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.